• #1 in global biotech and pharma licensing transactions 2010 – 2015

---

• #1 in issuer-side life sciences IPOs since 2000

---

• #1 in life sciences venture financings 2013 – 2015

---

• 180+ life sciences M&A transactions since 2010

---

• 50+ major corporate partnering and licensing deals in 2015

---

• Dedicated, international practice group of 40+ professionals across the US, UK and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies

Read more

• #1 for defending pharmaceutical companies in securities litigation matters over the past 5 years

---

• Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court

---

• Complete wins in commercially significant drug ownership and licensing disputes 

---

•  Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

---

•  Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act  violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers

---

• Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies

---

• Team includes 7 Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers

---

• Ranked #4 Most Innovative Law Firm by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients 

Read more

• Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking 

---

• Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors

---

• As connectors to the ecosystem, we counsel clients on how to launch innovative products and services

---

• Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience

---

• Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers

---

• Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications

---

• Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing

Read more

• 70+ person life sciences patent team across the US and UK (90% hold PhDs)

---

• The largest life sciences patent practice in the US

---

• In the last 5 years, prepared and filed nearly 10,000 patent applications

---

• 150+ investor-side and company-side patent due diligence reviews since 2015

---

• One of the most active IP litigation practices in the US with 500+ cases in the last 5 years

---

• Complete wins in commercially significant drug ownership and licensing disputes

---

• Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies 

---

• Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names

---

• Finalist for The American Lawyer’s 2015 IP Litigation Department of the Year award for bet-the-company wins including for Gilead and Gevo

Read more